More articles from Commentary
- Teriparatide: Label changes and identifying patients for long-term use
The changes leave clinicians with the challenge of identifying appropriate patients.
- Statin intolerance and new lipid-lowering treatments
The benefits and safety of statin therapy are clear, but adverse effects continue to pose diagnostic and therapeutic challenges.
- What is causing the ‘long-hauler’ phenomenon after COVID-19?
We are still early in our understanding of COVID-19 and its many manifestations.
- Our evolving understanding of primary aldosteronism
Current screening and confirmatory testing lack sensitivity and carry a poor negative predictive value.
- Cleveland Clinic—A century of progress
No one in their right mind would want to return to the “good old days.”
- Cleveland Clinic Journal of Medicine: Evolution and a look ahead
Cleveland Clinic is 100 years old and has had a medical journal for 90 of those years.
- COVID-19 diagnostic testing and the psychology of precautions fatigue
Overuse of special precautions can lead to diminished vigilance.
- Prostate cancer screening and the role of PSA: A UK perspective
We advocate PSA screening for all middle-aged men, especially if they have risk factors.
- Is regular oxygen supplementation safe for obese postoperative patients?
Caution for some, but no evidence to support withholding it altogether.
- COVID-19 and flu: Dual threat, dual opportunity
Measures to combat COVID-19 can minimize the impact of flu, and vice versa.